Dense breasts: a review of reporting legislation and available supplemental screening options.

OBJECTIVE The objectives of this article are to discuss the Mammography Quality Standards Act (MQSA) and what it means for patients, define breast density and explain how it is measured, review the new state-based legislation regarding the reporting of dense breast tissue directly to patients and the possibility of an adjunct screening examination, describe possible supplemental screening options and the advantages and disadvantages of each, and outline the current shortcomings and unanswered questions regarding new legislation. CONCLUSION Breast density is now established as an independent risk factor for developing breast cancer irrespective of other known risk factors. Women with breast density in the upper quartile have an associated four to five times greater risk of developing breast cancer relative to women with breast density in the lower quartile. Many states have enacted or proposed legislation requiring mammographers to report to patients directly if they have dense breast tissue and recommend discussing the possibility of a supplemental screening examination with their physicians. However, there is currently no consensus as to whether a supplemental screening examination should be pursued or which modality to use. Possible supplemental screening modalities include ultrasound, MRI, digital breast tomosynthesis, and molecular breast imaging. The U.S. Food and Drug Administration recently approved an automated breast ultrasound system for screening whole-breast ultrasound in patients with dense breasts. However, many questions are still unanswered including the impact on morbidity and mortality, cost-effectiveness, and insurance coverage.

[1]  N. Boyd,et al.  Mammographic density and the risk and detection of breast cancer. , 2007, The New England journal of medicine.

[2]  L. Kolonel,et al.  A Longitudinal Investigation of Mammographic Density: The Multiethnic Cohort , 2006, Cancer Epidemiology Biomarkers & Prevention.

[3]  S. Schnitt,et al.  Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  Manuela Durando,et al.  A first evaluation of breast radiological density assessment by QUANTRA software as compared to visual classification. , 2012, Breast.

[5]  G. Colditz,et al.  Mammographic breast density and breast cancer risk by menopausal status, postmenopausal hormone use and a family history of breast cancer , 2012, Cancer Causes & Control.

[6]  K. Kelly,et al.  Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts , 2009, European Radiology.

[7]  J. Youk,et al.  Radiologist assessment of breast density by BI-RADS categories versus fully automated volumetric assessment. , 2013, AJR. American journal of roentgenology.

[8]  J. Wolfe,et al.  Mammographic features and breast cancer risk: effects with time, age, and menopause status. , 1995, Journal of the National Cancer Institute.

[9]  X. Castells,et al.  Inter- and intraradiologist variability in the BI-RADS assessment and breast density categories for screening mammograms. , 2012, The British journal of radiology.

[10]  O. Olsen.  Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. , 2002, Cancer.

[11]  Dana H Whaley,et al.  Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts. , 2011, Radiology.

[12]  Karen Drukker,et al.  Interreader scoring variability in an observer study using dual-modality imaging for breast cancer detection in women with dense breasts. , 2013, Academic radiology.

[13]  J. Sampalis,et al.  Breast Cancer Diagnosis by Scintimammography: A Meta-analysis and Review of the Literature , 2003, Breast Cancer Research and Treatment.

[14]  L. Tabár,et al.  Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening , 2003, The Lancet.

[15]  N. Ohuchi,et al.  Randomized Controlled Trial on Effectiveness of Ultrasonography Screening for Breast Cancer in Women Aged 40–49 (J-START): Research Design , 2010, Japanese journal of clinical oncology.

[16]  Rachel F Brem,et al.  Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. , 2008, Radiology.

[17]  S. Ciatto,et al.  Role of ultrasonography in detecting mammographically occult breast carcinoma in women with dense breasts , 2006, La radiologia medica.

[18]  D B Plewes,et al.  Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  T M Svahn,et al.  Breast tomosynthesis and digital mammography: a comparison of diagnostic accuracy. , 2012, The British journal of radiology.

[20]  M. O’Connor,et al.  Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors. , 2008, AJR. American journal of roentgenology.

[21]  Maximilian Reiser,et al.  Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  T. Sellers,et al.  Mammographic density, breast cancer risk and risk prediction , 2007, Breast Cancer Research.

[23]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.

[24]  I. Mena,et al.  Prone scintimammography in patients with suspicion of carcinoma of the breast. , 1994, Journal of the American College of Surgeons.

[25]  A. Degnim,et al.  Scientific Impact Recognition Award: Molecular breast imaging: a review of the Mayo Clinic experience. , 2008, American journal of surgery.

[26]  Woo Kyung Moon,et al.  Breast cancers initially detected by hand-held ultrasound: detection performance of radiologists using automated breast ultrasound data , 2011, Acta radiologica.

[27]  Robert W. Maxwell,et al.  Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. Part II. Evaluation in patients. , 2012, Medical physics.

[28]  L. Philpotts,et al.  Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. , 2012, Radiology.

[29]  Håkan Jonsson,et al.  Reduction in Breast Cancer Mortality from Organized Service Screening with Mammography: 1. Further Confirmation with Extended Data , 2006, Cancer Epidemiology Biomarkers & Prevention.

[30]  Madhavi Raghu,et al.  Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. , 2013, Radiology.

[31]  L. Philpotts,et al.  Breast ultrasonography: state of the art. , 2013, Radiology.

[32]  David Gur,et al.  Digital breast tomosynthesis: observer performance study. , 2009, AJR. American journal of roentgenology.

[33]  R. Wahl,et al.  New methods for imaging the breast: techniques, findings, and potential. , 1995, AJR. American journal of roentgenology.

[34]  Javier Villanueva-Meyer,et al.  (99m)Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study. , 2002, Radiology.

[35]  S. Ciatto,et al.  Interobserver agreement in breast radiological density attribution according to BI-RADS quantitative classification , 2012, La radiologia medica.

[36]  Laurie L Fajardo,et al.  Breast tomosynthesis: present considerations and future applications. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[37]  R. Fimmers,et al.  Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  Deepa Narayanan,et al.  Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[39]  Etta D Pisano,et al.  Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. , 2012, JAMA.

[40]  V. Shane Pankratz,et al.  Mammographic Breast Density as a General Marker of Breast Cancer Risk , 2007, Cancer Epidemiology Biomarkers & Prevention.

[41]  Jean B. Cormack,et al.  Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. , 2008, JAMA.

[42]  T. M. Kolb,et al.  Occult cancer in women with dense breasts: detection with screening US--diagnostic yield and tumor characteristics. , 1998, Radiology.

[43]  M. O’Connor,et al.  Nuclear imaging of the breast: translating achievements in instrumentation into clinical use. , 2013, Medical physics.

[44]  R. Taillefer.  The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. , 1999, Seminars in nuclear medicine.

[45]  Mark A Helvie,et al.  Digital mammography imaging: breast tomosynthesis and advanced applications. , 2010, Radiologic clinics of North America.

[46]  C. Gatsonis,et al.  Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. , 2007, Radiology.

[47]  Amanda L. Weinmann,et al.  Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. Part I. Evaluation in phantoms. , 2012, Medical physics.

[48]  R. J. Brenner.  Dedicated Dual-Head Gamma Imaging for Breast Cancer Screening in Women with Mammographically Dense Breasts: Rhodes DJ, Hruska CB, Phillips SW, et al (Mayo Clinic, Rochester, MN) Radiology 258:106-118, 2010§ , 2011 .